Found 324 matching trials
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC PHASE2 This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Show More Location
Multiple Locations
Learn More & Join Trial
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer PHASE2 This prospective real-world study aims to evaluate the effectiveness and sa...
Show More Location
Air Force Military Medical University
Learn More & Join Trial
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer NA This study aims to evaluate the clinical feasibility of first-line immunoch...
Show More Location
The Obstetrics and Gynecology Hospital of Fudan University
Learn More & Join Trial
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma PHASE2 The aim of the study is to determine if intervening with combined local the...
Show More Location
Fudan Universtiy Shanghai Cancer Center
Learn More & Join Trial
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant PHASE2 RATIONALE: Antifungals, such as caspofungin acetate, may be effective in tr...
Show More Location
CHU Liege - Domaine Universitaire du Sart Tilman
Learn More & Join Trial
Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) PHASE2 This is a single-center, randomized, open-label, parallel-controlled clinic...
Show More Location
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Learn More & Join Trial
a Retrospective Study on the Systemic Treatment of LPP and FFA N/A This retrospective study aims to assess the effectiveness of systemic treat...
Show More Learn More & Join Trial
Change in Body Weight During Treatment of Advanced Colorectal Cancer N/A Colorectal cancer (CRC) is a significant and growing health burden in Hong ...
Show More Location
Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun
Learn More & Join Trial
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial